The effects of RAF/RAS mutations on the melanoma metabolism include stimulating MYC and HIF1α signaling to promote glycolysis, as well as the inhibition of mitochondrial oxidative phosphorylation (OXPHOS) by repressing MITF and PGC1α, and promoting fatty acid synthesis. Here, MITF is linked to melanoma.